Clinical Stage III Gastric Cancer AJCC v8 Completed Phase 0 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0113386 (Clinical Stage III Gastric Cancer AJCC v8)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03395847Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal AdenocarcinomaTreatment